LifeStance Health Group/$LFST
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LifeStance Health Group
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
Ticker
$LFST
Sector
Primary listing
Employees
7,708
Headquarters
Website
LFST Metrics
BasicAdvanced
$2B
-
-$0.04
1.13
-
Price and volume
Market cap
$2B
Beta
1.13
52-week high
$8.30
52-week low
$3.74
Average daily volume
1.6M
Financial strength
Current ratio
1.481
Quick ratio
1.314
Long term debt to equity
28.244
Total debt to equity
32.176
Interest coverage (TTM)
0.12%
Profitability
EBITDA (TTM)
60.054
Gross margin (TTM)
32.52%
Net profit margin (TTM)
-1.23%
Operating margin (TTM)
0.19%
Effective tax rate (TTM)
25.47%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
0.04%
Return on equity (TTM)
-1.11%
Valuation
Price to revenue (TTM)
1.512
Price to book
1.37
Price to tangible book (TTM)
-596.67
Price to free cash flow (TTM)
16.575
Free cash flow yield (TTM)
6.03%
Free cash flow per share (TTM)
0.314
Growth
Revenue change (TTM)
13.86%
Earnings per share change (TTM)
-89.57%
3-year revenue growth (CAGR)
19.24%
3-year earnings per share growth (CAGR)
-65.53%
What the Analysts think about LFST
Analyst ratings (Buy, Hold, Sell) for LifeStance Health Group stock.
Bulls say / Bears say
LifeStance reported Q2 2025 revenue of $345.3 million, up 11% year-over-year, driven by a 12% increase in visit volumes and an 11% increase in its clinician base. (Nasdaq)
The company achieved record free cash flow of $56.6 million in Q2 2025 and increased Adjusted EBITDA by 19% to $34.0 million, pushing its Adjusted EBITDA margin to 9.8%. (Nasdaq)
Management raised its full-year 2025 guidance, lifting the midpoint of Adjusted EBITDA to $145 million (up $5 million) and center margin to $453 million, reflecting confidence in ongoing growth. (Nasdaq)
LifeStance remained unprofitable in Q2 2025 with a GAAP net loss of $3.8 million, underscoring that its path to consistent profitability is still uncertain. (Nasdaq)
In Q1 2025, the company had negative free cash flow of $10.3 million, highlighting challenges in turning accounting profits into operating cash. (Nasdaq)
As of June 30, 2025, LifeStance had net long-term debt of $272.9 million compared to cash balances of $188.9 million, indicating a leveraged balance sheet that could constrain financial flexibility. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2025.
LFST Financial Performance
Revenues and expenses
LFST Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LifeStance Health Group stock?
LifeStance Health Group (LFST) has a market cap of $2B as of October 27, 2025.
What is the P/E ratio for LifeStance Health Group stock?
The price to earnings (P/E) ratio for LifeStance Health Group (LFST) stock is 0 as of October 27, 2025.
Does LifeStance Health Group stock pay dividends?
No, LifeStance Health Group (LFST) stock does not pay dividends to its shareholders as of October 27, 2025.
When is the next LifeStance Health Group dividend payment date?
LifeStance Health Group (LFST) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeStance Health Group?
LifeStance Health Group (LFST) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.